Table 1 |
|
|
Clinicopathological features of patients with perforated gastric cancer. |
|
| Variable |
Number of Patients |
|
|
|
| Age |
|
| Range (yr)/Mean |
41–73/59 |
| Sex |
|
| Male |
10/13 |
| Female |
3/13 |
| Preoperative diagnosis |
|
| Perforation |
11/13 |
| Cancer |
2/13 |
| Location-Perforation side |
|
| Lower third |
3/10 |
| Middle third |
5/10 |
| Upper third |
5/10 |
| Serosal invasion |
|
| Absent |
0/13 |
| Present |
13/13 |
| Lymph node metastasis |
|
| Absent |
1/13 |
| Present |
12/13 |
| Stage of disease |
|
| I |
0/13 |
| II |
1/13 |
| III |
2/13 |
| IV |
10/13 |
| Surgery |
|
| Gastrectomy |
7/13 |
| Total |
4/13 |
| Subtotal |
3/13 |
| Local repair |
6/13 |
| Lymph node dissection |
|
| Extended (D2, D3) |
0/13 |
| Limited (D0, D1) |
7/13 |
|
|
|
|
Kotan et al. World Journal of Emergency Surgery 2008 3:17 doi:10.1186/1749-7922-3-17 |
|
